GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » LT-Debt-to-Total-Asset

Microba Life Sciences (ASX:MAP) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Microba Life Sciences's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Microba Life Sciences's long-term debt to total assets ratio declined from Dec. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Microba Life Sciences is progressively becoming less dependent on debt to grow their business.


Microba Life Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Microba Life Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences LT-Debt-to-Total-Asset Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
LT-Debt-to-Total-Asset
0.01 0.01

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
LT-Debt-to-Total-Asset 0.02 0.01 0.01 0.01 0.01

Microba Life Sciences LT-Debt-to-Total-Asset Calculation

Microba Life Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (A: Jun. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2023 )/Total Assets (A: Jun. 2023 )
=0.234/46.953
=0.00

Microba Life Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=0.511/65.236
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microba Life Sciences  (ASX:MAP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Microba Life Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines